HealthTech BioActives (HTBA), a manufacturer of citrus flavonoids and active forms of vitamin B12, has injected €25 million (US$26 million) into modernizing its research, development, and manufacturing center in Murcia, Spain.
The initiative included the construction of a new state-of-the-art production plant, which was officially inaugurated on January 28, making HTBA the only company in Europe capable of producing all active forms of vitamin B12.